SEC-sourced researchBeta
SILO
Silo Pharma, Inc.
Company comparison ↗
Data passport
- CIK
- 0001514183
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Nov 18, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 72,102.0000 | Mar 27, 2026 |
| December 2025 | 72,102.0000 | Mar 27, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 72,102.0000 | -4,227,698.0000 | -4,661,339.0000 | 7,605,100.0000 | 1,299,659.0000 | Mar 27, 2026 |
| December 2024 | 72,102.0000 | -4,392,880.0000 | -3,833,914.0000 | 7,411,840.0000 | 2,377,575.0000 | Mar 27, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $72.1K | December 2025 | Mar 27, 2026 | 10-K |
| Previous period revenueRevenues | $72.1K | December 2024 | Mar 27, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$4.23M | December 2025 | Mar 27, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$4.66M | December 2025 | Mar 27, 2026 | 10-K |
| Total assetsAssets | $7.61M | December 2025 | Mar 27, 2026 | 10-K |
| Total liabilitiesLiabilities | $1.3M | December 2025 | Mar 27, 2026 | 10-K |
New filings
- S-3SILO · Silo Pharma, Inc.Nov 18, 2026 · Other
- SCHEDULE 13GSILO · Silo Pharma, Inc.Nov 16, 2026 · Other
- 10-QSILO · Silo Pharma, Inc.Nov 13, 2026 · Periodic
- SCHEDULE 13G/ASILO · Silo Pharma, Inc.Nov 10, 2026 · Other
- 8-KSILO · Silo Pharma, Inc.Nov 6, 2026 · Current event
- 8-KSILO · Silo Pharma, Inc.Oct 14, 2026 · Current event
- 8-KSILO · Silo Pharma, Inc.Oct 2, 2026 · Current event